LISETTE LUGO-CALZADA
Allopathic & Osteopathic Physicians|Pediatrics SAN JUAN, PR NPI 1497783542
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics PR GENZYME CORPORATION All categories
General Payments — all program years on this page
$805.64
- Category: General Payments
- Program years: PY2018–2024
- Record count: 19
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $495.48 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $495.48 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $251.87 | 4 |
| Genentech, Inc. | $111.35 | 1 |
| ACADIA Pharmaceuticals Inc | $61.42 | 1 |
| NS Pharma, Inc. | $52.39 | 1 |
| Genentech USA, Inc. | $18.45 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1133055364 | Genentech USA, Inc. | $18.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133055368 | Genentech, Inc. | $111.35 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139459514 | NS Pharma, Inc. | $52.39 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139958363 | GENZYME CORPORATION | $101.60 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139958365 | GENZYME CORPORATION | $32.77 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139958377 | GENZYME CORPORATION | $20.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139958401 | GENZYME CORPORATION | $97.50 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147982760 | ACADIA Pharmaceuticals Inc | $61.42 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.